Insider · CIK 0001313390

Duvall Martin J

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001313390

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-10-04	FBRXForte Biosciences, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	50,000
2019-05-28	FBRXForte Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,000 sh	$4.34	+$21.7K	13,605
2019-03-01	FBRXForte Biosciences, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+160K sh	—	—	160,000
2018-03-01	FBRXForte Biosciences, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2017-12-08	FBRXForte Biosciences, Inc.J Other	Director, Chief Executive Officer	JOther	+2,500 sh	$8.50	+$21.3K	6,071
2017-05-26	FBRXForte Biosciences, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+285K sh	—	—	285,000
2017-04-19	FBRXForte Biosciences, Inc.J Other	Director, Chief Executive Officer	JOther	+3,571 sh	$10.00	+$35.7K	3,571
2017-04-12	FBRXForte Biosciences, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+46.7K sh	—	—	46,739
2016-04-29	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+18K sh	—	—	111,039
2016-04-29	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−18K sh	—	—	0
2016-04-29	ARIAD PHARMACEUTICALS INCF Tax Payment	EVP, CCO	FTax Payment	−5,850 sh	$7.18	−$42K	105,189
2016-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+8,000 sh	—	—	97,039
2016-03-19	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−4,000 sh	$6.47	−$25.9K	93,039
2016-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−8,000 sh	—	—	0
2016-03-07	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	EVP, CCO	AAward	+26.2K sh	—	—	26,180
2016-03-07	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	EVP, CCO	AAward	+87.1K sh	—	—	87,125
2016-03-03	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−9,625 sh	$6.12	−$58.9K	89,039
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−19.3K sh	—	—	19,250
2016-03-01	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	EVP, CCO	AAward	+38.5K sh	—	—	38,500
2016-03-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+19.3K sh	—	—	98,664
2016-02-01	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−14.7K sh	$4.81	−$70.6K	79,414
2016-02-01	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+29.3K sh	—	—	94,081
2016-02-01	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−29.3K sh	—	—	29,333
2015-09-28	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−5,000 sh	$6.46	−$32.3K	64,748
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitA Award	EVP, CCO	AAward	+20K sh	—	—	20,000
2015-09-24	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+10K sh	—	—	69,748
2015-09-24	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−10K sh	—	—	10,000
2015-07-16	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−1,400 sh	$8.54	−$12K	59,748
2015-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−2,800 sh	—	—	0
2015-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+2,800 sh	—	—	61,148
2015-04-29	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	EVP, CCO	AAward	+54K sh	—	—	54,000
2015-03-23	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−834 sh	$8.57	−$7,145.045	54,950
2015-03-20	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−4,000 sh	$8.85	−$35.4K	54,117
2015-03-20	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−1,667 sh	—	—	55,784
2015-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−1,667 sh	—	—	0
2015-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+8,000 sh	—	—	58,117
2015-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−8,000 sh	—	—	8,000
2015-02-02	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−29.3K sh	—	—	58,666
2015-02-02	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+29.3K sh	—	—	64,784
2015-02-02	ARIAD PHARMACEUTICALS INCS Sale	EVP, CCO	SSale	−14.7K sh	$6.33	−$92.8K	50,117
2014-07-15	ARIAD PHARMACEUTICALS INCF Tax Payment	EVP, CCO	FTax Payment	−913 sh	$5.57	−$5,085.41	35,450
2014-07-15	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+2,800 sh	—	—	36,363
2014-07-15	ARIAD PHARMACEUTICALS INCPerformance stock unitM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−2,800 sh	—	—	2,800
2014-03-20	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+1,666 sh	—	—	30,869
2014-03-20	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−1,666 sh	—	—	1,667
2014-03-20	ARIAD PHARMACEUTICALS INCF Tax Payment	EVP, CCO	FTax Payment	−529 sh	$8.13	−$4,300.77	30,340
2014-03-19	ARIAD PHARMACEUTICALS INCF Tax Payment	EVP, CCO	FTax Payment	−2,618 sh	$8.19	−$21.4K	29,203
2014-03-19	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	EVP, CCO	MExercise/Conversion	−8,000 sh	—	—	16,000
2014-03-19	ARIAD PHARMACEUTICALS INCM Exercise/Conversion	EVP, CCO	MExercise/Conversion	+8,000 sh	—	—	31,821
2014-01-31	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsA Award	EVP, CCO	AAward	+88K sh	—	—	88,000

Recent filings

Accepted (ET)
Oct 44
Duvall Martin J0001209191-19-052620
SEC(opens sec.gov)
May 294
Duvall Martin J0001209191-19-033190
SEC(opens sec.gov)
Mar 54
Duvall Martin J0001209191-19-016896
SEC(opens sec.gov)
Mar 24
Duvall Martin J0001209191-18-015824
SEC(opens sec.gov)
Dec 144
Duvall Martin J0001209191-17-065788
SEC(opens sec.gov)
May 314
Tocagen Inc0001209191-17-036617
SEC(opens sec.gov)
Apr 214
Tocagen Inc0001209191-17-027908
SEC(opens sec.gov)
Apr 124
Tocagen Inc0001209191-17-026750
SEC(opens sec.gov)
May 24
ARIAD PHARMACEUTICALS INC0000884731-16-000038
SEC(opens sec.gov)
Mar 224
ARIAD PHARMACEUTICALS INC0000884731-16-000025
SEC(opens sec.gov)
Mar 94
ARIAD PHARMACEUTICALS INC0001628280-16-012500
SEC(opens sec.gov)
Mar 34
ARIAD PHARMACEUTICALS INC0001127602-16-044965
SEC(opens sec.gov)

Companies

Address

C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139